These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30654768)

  • 1. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
    BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of podoplanin in the biology of differentiated thyroid cancers.
    Rudzińska M; Gaweł D; Sikorska J; Karpińska KM; Kiedrowski M; Stępień T; Marchlewska M; Czarnocka B
    PLoS One; 2014; 9(5):e96541. PubMed ID: 24797369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing.
    Mielecki D; Gajda E; Sikorska J; Betkowska A; Rozwadowski M; Gawel AM; Kulecka M; Zeber-Lubecka N; Godlewska M; Gawel D
    Comput Struct Biotechnol J; 2023; 21():3810-3826. PubMed ID: 37560122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of MAPK pathway inhibitors on migration and invasiveness of BRAF(V600E) mutant thyroid cancer cells in 2D and 3D culture.
    Ingeson-Carlsson C; Martinez-Monleon A; Nilsson M
    Exp Cell Res; 2015 Nov; 338(2):127-35. PubMed ID: 26384551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (V600E)BRAF promotes invasiveness of thyroid cancer cells by decreasing E-cadherin expression through a Snail-dependent mechanism.
    Baquero P; Sánchez-Hernández I; Jiménez-Mora E; Orgaz JL; Jiménez B; Chiloeches A
    Cancer Lett; 2013 Jul; 335(1):232-41. PubMed ID: 23435375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
    BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition.
    Schweppe RE; Kerege AA; Sharma V; Poczobutt JM; Gutierrez-Hartmann A; Grzywa RL; Haugen BR
    Thyroid; 2009 Aug; 19(8):825-35. PubMed ID: 19500021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells.
    Revilla G; Ruiz-Auladell L; Vallverdú NF; Santamaría P; Moral A; Pérez JI; Li C; Fuste V; Lerma E; Corcoy R; Pitoia F; Escolà-Gil JC; Mato E
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of urinary-type plasminogen activator correlates with high-risk papillary thyroid carcinoma with BRAF(V600E) mutation and its possible molecular mechanism.
    Wakasa T; Li Y; Bai Y; Liu Z; Ozaki T; Mori I; Miyauchi A; Kakudo K; Nakamura M
    Pathol Res Pract; 2014 Nov; 210(11):733-8. PubMed ID: 25085839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma.
    Gaweł AM; Ratajczak M; Gajda E; Grzanka M; Paziewska A; Cieślicka M; Kulecka M; Oczko-Wojciechowska M; Godlewska M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
    Henderson YC; Fredrick MJ; Clayman GL
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):810-5. PubMed ID: 17709622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells.
    Wu J; Zhang H; Zhang W; Zhang J; Lin X; Xue G; Gao F
    Neoplasma; 2018; 65(2):169-177. PubMed ID: 29534576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells.
    Ou-Yang M; Liu HR; Zhang Y; Zhu X; Yang Q
    Biochimie; 2011 May; 93(5):954-61. PubMed ID: 21352885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin].
    Tao XF; Liu C; Bai Y; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):761-3. PubMed ID: 22177047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.
    Martín-Villar E; Megías D; Castel S; Yurrita MM; Vilaró S; Quintanilla M
    J Cell Sci; 2006 Nov; 119(Pt 21):4541-53. PubMed ID: 17046996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Properties of the Antisense lncRNA
    Esposito R; Esposito D; Pallante P; Fusco A; Ciccodicola A; Costa V
    Cancer Res; 2019 May; 79(9):2124-2135. PubMed ID: 30862713
    [No Abstract]   [Full Text] [Related]  

  • 20. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
    Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
    Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.